1. Home
  2. EBS

EBS

Emergent Biosolutions Inc.

Logo Emergent Biosolutions Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

Founded: 1998 Country:
United States
United States
Employees: N/A City: GAITHERSBURG
Market Cap: 114.3M IPO Year: 2006
Target Price: $5.00 AVG Volume (30 days): 3.1M
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -14.85 EPS Growth: N/A
52 Week Low/High: $1.42 - $12.87 Next Earning Date: 05-07-2024
Revenue: $1,049,300,000 Revenue Growth: -6.10%
Revenue Growth (this year): -1.36% Revenue Growth (next year): 9.86%

Share on Social Networks: